Related Experiment Video

Updated: Jun 25, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Long QT syndrome in extensive infective endocarditis complicating hypertrophic obstructive cardiomyopathy

Shi-Min Yuan1, Eugene Demesthenous, Vera Coman

  • 1The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel. shi_min_yuan@yahoo.com

Kardiologia Polska
|March 3, 2009
PubMed

Insights

Infective endocarditis is rare in hypertrophic obstructive cardiomyopathy. This case highlights successful urgent surgery for extensive endocarditis in a patient with mild hypertrophic obstructive cardiomyopathy and long QT syndrome.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Genetics

Background:

  • Infective endocarditis (IE) is uncommon in patients with hypertrophic obstructive cardiomyopathy (HOCM).
  • Long QT syndrome (LQTS) is a cardiac channelopathy that can increase the risk of arrhythmias.
  • The co-occurrence of IE, HOCM, and LQTS presents unique clinical challenges.

Observation:

  • A female patient with mild HOCM and LQTS developed extensive IE.
  • The patient presented with clinical features suggestive of severe infection and cardiac compromise.
  • Diagnostic workup confirmed the presence of extensive vegetations on the heart valves.

Findings:

  • An urgent surgical intervention was performed to address the extensive IE.
  • The patient experienced an uneventful postoperative recovery, indicating successful management.
  • Clinical features and potential mechanisms contributing to LQTS in this context were analyzed.

Implications:

  • This case underscores the importance of considering IE in HOCM patients, even with mild obstruction.
  • Successful surgical management of IE in this complex patient profile is feasible.
  • Further investigation into the interplay between HOCM, LQTS, and IE may refine treatment strategies.

More Related Videos

Electrocardiogram Recordings in Anesthetized Mice using Lead II04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...